Open Question

Celgene is acquiring Pharmion for $2.9B. They've partnered before and PHRM seems
to have drugs approved and in development that compliment CELG's current
portfolio and pipeline. What are the pickr's thoughts?

Asked by Cohen 9 months ago - 3 answers - 348 views
previous pagePage 1 of 1next page
Go to page:go

I went back to take a look at holx and ima. both stocks went down after the
acquisition announcements. I woul wait until Wednesday to start a position.

Holx opened down 4.5% and that was the high for the day. Dropped down to $51
before coming back up to close at $54. It dropped back down to $51 the
preceeding days. That was the lows until the August correction.

Answered by ejg62 - Bookmark this User - Ignore this user
9 months ago - Report Abuse

Rate Now: 1 2 3 4 Average Rating: 0.00 / 0

well, i dont like that they are buying it 2/3 with stock, even though it's
partial cash. I agree with the previous poster about arbitrage, might even play
it myself. I think there is a good chance we can buy some more shares at a lower
price i.e. BHP, and this should be good for long term shareholders because as
you mentioned it should help the pipeline.

I'd say 61 is a good place to add more shares or buy in for those that may not
be in already, back up the truck at 56.

Rate Now: 1 2 3 4 Average Rating: 0.00 / 0

Ah #@*%!!! I own celg on on account and a bull call spread in another account.
I am thinking of what took place with holx, the stock collapsed from low 60's to
low 50's as the arb's changed how they approached the 2 stocks.

The fact there is a 46% premium for phrm and there will be a negative impact on
2008 earning, I believe the same will happen here.

Answered by ejg62 - Bookmark this User - Ignore this user
9 months ago - Report Abuse

Rate Now: 1 2 3 4 Average Rating: 0.00 / 0

previous pagePage 1 of 1next page
Go to page:go